Ribonuclease A (RNase A) is increasingly
considered as a biomarker
for tumor diagnosis, and it is of great significance to develop an
ultrasensitive, cost-effective assay for RNase A detection. Electrochemiluminescence
(ECL) technology has distinctive advantages in the development of
biosensors for diverse targets. However, most of the ECL biosensors
require the complex process of electrode modification, which is laborious
and time consuming. In this work, an immobilization-free homogeneous
ECL assay was developed for the highly sensitive detection of RNase
A activity for the first time. On the basis of the fact that RNase
A can specifically hydrolyze RNA at the site of ribonucleotide uracil
(rU), a rU-containing chimeric DNA probe is designed and labeled with
Ru(bpy)3
2+ (act as ECL indicator). The chimeric
DNA probe hardly diffuses to the surface of negatively charged indium
tin oxide (ITO) electrode due to the strong electrostatic repulsion
between the negatively charged DNA and ITO electrode, resulting in
a weak ECL signal detected. When the RNase A is present, the chimeric
DNA probe is hydrolyzed into small fragments, which contains little
negative charge and can diffuse easily to the ITO electrode surface
due to the decreased electrostatic repulsion. In this case, an enhanced
ECL signal can be detected. Under the optimal conditions, there is
a linear relationship between the ECL signal and the concentration
of RNase A in the range of 0.001–0.10 ng/mL, and the detection
limit is 0.2 pg/mL. In addition, the proposed ECL sensing system is
also applied to detect the RNase A inhibitor, taking As3+ as an example. The proposed homogeneous ECL sensing system provides
a new approach for the highly sensitive and convenient detection of
RNase A as well as other ribonucleases only by redesigning a responding
chimeric DNA probe.